Evidence map›Paper›PMID 30639241›Full record

ArticleMolecular cell2019

Efficient Pre-mRNA Cleavage Prevents Replication-Stress-Associated Genome Instability.

Federico Teloni, Jone Michelena, Aleksandra Lezaja, Sinan Kilic, Christina Ambrosi, Shruti Menon, Jana Dobrovolna, Ralph Imhof, Pavel Janscak, Tuncay Baubec and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular cell, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
4.2field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 95 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Federico TeloniDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland; Life Science Zurich Graduate School (LSZGS), 8057 Zurich, Switzerland.
Jone MichelenaDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Aleksandra LezajaDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland; Life Science Zurich Graduate School (LSZGS), 8057 Zurich, Switzerland.
Sinan KilicDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Christina AmbrosiDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland; Life Science Zurich Graduate School (LSZGS), 8057 Zurich, Switzerland.
Shruti MenonInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland; Life Science Zurich Graduate School (LSZGS), 8057 Zurich, Switzerland.
Jana DobrovolnaInstitute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 143 00 Czech Republic.
Ralph ImhofDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Pavel JanscakInstitute of Molecular Cancer Research, University of Zurich, 8057 Zurich, Switzerland; Institute of Molecular Genetics, Academy of Sciences of the Czech Republic, Videnska 1083, 143 00 Czech Republic.
Tuncay BaubecDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland.
Matthias AltmeyerDepartment of Molecular Mechanisms of Disease, University of Zurich, 8057 Zurich, Switzerland. Electronic address: matthias.altmeyer@uzh.ch.
University of Zurich · CHLife Science Zurich · CHCzech Academy of Sciences, Institute of Molecular Genetics · CZ

Funding

European Research Council 714326
6 · The paper itself

Abstract

Cellular mechanisms that safeguard genome integrity are often subverted in cancer. To identify cancer-related genome caretakers, we employed a convergent multi-screening strategy coupled to quantitative image-based cytometry and ranked candidate genes according to multivariate readouts reflecting viability, proliferative capacity, replisome integrity, and DNA damage signaling. This unveiled regulators of replication stress resilience, including components of the pre-mRNA cleavage and polyadenylation complex. We show that deregulation of pre-mRNA cleavage impairs replication fork speed and leads to excessive origin activity, rendering cells highly dependent on ATR function. While excessive formation of RNA:DNA hybrids under these conditions was tightly associated with replication-stress-induced DNA damage, inhibition of transcription rescued fork speed, origin activation, and alleviated replication catastrophe. Uncoupling of pre-mRNA cleavage from co-transcriptional processing and export also protected cells from replication-stress-associated DNA damage, suggesting that pre-mRNA cleavage provides a mechanism to efficiently release nascent transcripts and thereby prevent gene gating-associated genomic instability.

Indexed as

DNA DamageDNA ReplicationGenomic InstabilityRNA CleavageActive Transport, Cell NucleusCell Cycle ProteinsDNA-Binding ProteinsDNA, NeoplasmGene Expression Regulation, NeoplasticHeLa CellsHumansNeoplasmsNuclear ProteinsNucleic Acid HeteroduplexesPolyadenylationRNA-Binding ProteinsCell Cycle ProteinsDNA-Binding ProteinsDNA, NeoplasmNuclear ProteinsNucleic Acid HeteroduplexesRNA-Binding ProteinsRNA, MessengerRNA, NeoplasmRNA PrecursorsTHOC1 protein, humanWDR33 protein, humanATRcheckpoint activationcleavagegene gatingorigin firingpolyadenylationpre-mRNA processingreplication catastrophereplication stressR-loopsRNA:DNA hybrids

Identifiers

PMID30639241
PMCPMC6395949
OpenAlexW2910670142

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.